VRDNViridian Therapeutics, Inc.
VRDN holders
Who holds Viridian Therapeutics, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
- Managers
- 234
- Shares held
- 137.3M
- Value held
- $2.7B
- Opened
- 42
- Closed
- 23
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.